Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1−/− mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.
At a glance
Gene Expression Omnibus
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905–914 (1991) et al.
- Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711–1714 (1991) et al.
- Abnormal pattern detected in fragile-X patients by pulsed-field gel electrophoresis. Nature 349, 624–626 (1991) et al.
- The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74, 291–298 (1993) , , &
- FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262, 563–566 (1993) , , &
- Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. J. Biol. Chem. 273, 15521–15527 (1998) et al.
- Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489–499 (2001) et al.
- Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nature Genet. 4, 244–251 (1993) et al.
- Alternative splicing in the fragile X gene FMR1. Hum. Mol. Genet. 2, 399–404 (1993) et al.
- A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nature Genet. 3, 31–35 (1993) et al.
- Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 77, 33–39 (1994) , , , &
- FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1, 109–118 (1997) et al.
- A nuclear role for the Fragile X mental retardation protein. EMBO J. 15, 5408–5414 (1996) , , , &
- Transport of Drosophila fragile X mental retardation protein-containing ribonucleoprotein granules by kinesin-1 and cytoplasmic dynein. Proc. Natl Acad. Sci. USA 101, 17428–17433 (2004) , , &
- The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum. Mol. Genet. 16, 3047–3058 (2007) et al.
- A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev. Cell 14, 926–939 (2008) , , , &
- The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes. Hum. Mol. Genet. 6, 1465–1472 (1997) et al.
- FMR1: a gene with three faces. Biochim. Biophys. Acta 1790, 467–477 (2009) &
- Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis. Adv. Exp. Med. Biol. 970, 517–551 (2012) , , , &
- Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Neuropsychopharmacology 37, 178–195 (2012) , &
- Fragile X syndrome and targeted treatment trials. Results Probl. Cell Differ. 54, 297–335 (2012) , , &
- FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011) et al.
- Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu. Rev. Med. 62, 411–429 (2011) &
- The state of synapses in fragile X syndrome. Neuroscientist 15, 549–567 (2009) &
- Fragile X syndrome and autism at the intersection of genetic and neural networks. Nature Neurosci. 9, 1221–1225 (2006) &
- Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477–487 (2001) et al.
- Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60, 201–214 (2008) &
- Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129–141 (2010) et al.
- HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456, 464–469 (2008) et al.
- Identification of RNA–protein interaction networks using PAR-CLIP. Wiley Interdiscip. Rev. RNA 3, 159–177 (2012) , , , &
- A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA 101, 6062–6067 (2004) et al.
- Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008) et al.
- A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nature Methods 8, 559–564 (2011) et al.
- PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol. 12, R79 (2011) et al.
- Evidence-ranked motif identification. Genome Biol. 11, R19 (2010) et al.
- FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 5, e52 (2007) &
- The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20, 4803–4813 (2001) et al.
- Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X-related proteins as components of the complex. Mol. Cell. Biol. 19, 7925–7932 (1999) , &
- The pathophysiology of fragile X (and what it teaches us about synapses). Annu. Rev. Neurosci. 35, 417–443 (2012) , &
- The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704–716 (2010) et al.
- Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch–Belgian Fragile X Consortium. Cell 78, 23–33 (1994) et al.
- Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J. Neurosci. 30, 10624–10638 (2010) et al.
- Dysregulation of mTOR signaling in fragile X syndrome. J. Neurosci. 30, 694–702 (2010) et al.
- Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63–68 (2011) , &
- Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J. Neurosci. 31, 8862–8869 (2011) , , , &
- Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex. Neurobiol. Dis. 45, 1101–1110 (2012) et al.
- 2013) et al. in Handbook of RNA Biochemistry Vol. 1 (eds , , & ) (Wiley-VCH,
- DNA familial binding profiles made easy: comparisons of various motif alignment and clustering strategies. PLoS Comp. Biol. 3, e61 (2007) , &
- Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 14, 2580–2596 (2008) et al.
- affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307–315 (2004) , , &
- Supplementary Figures (6.1M)
This file contains Supplementary Figures 1-10.
- Supplementary Data (4.7M)
This zipped file contains Supplementary Tables 1 and 3-7.
- Supplementary Data (28M)
This zipped file contains Supplementary Tables 2a and 2b.
- Supplementary Data (24.6M)
This zipped file contains Supplementary Tables 2c and 2d.
- Supplementary Data (12.4M)
This zipped file contains Supplementary Table 2e.